Navigation Links
Cytos Biotechnology Reports Results from Phase IIa Study with,CYT003-QbG10 in Patients Suffering from Atopic Dermatitis

y Index (EASI), a commonly applied test for AD. The study participants were randomized into two treatment groups with 18 patients each and received 6 weekly subcutaneous injections of either 300 ?g CYT003-QbG10 or placebo. Two weeks after the last dose, the disease status of the patients was again assessed by the EASI.

About allergic diseases and atopic dermatitis
Allergy as a whole is a multi-faceted disease and clinically manifests in various allergic disorders including allergic rhinitis, asthma, atopic dermatitis and food hypersensitivity. On the immunological level, so called T helper 2-type (Th2) immune responses are considered crucial for the initiation and maintenance of allergy. The prevalence of allergic diseases has dramatically increased over the last decades, especially in industrialized countries. It is estimated that today more than 20% of the world population suffers from allergic diseases1.

AD is a certain type of eczema. It is a common chronic skin disease considered to be linked to an “allergic” Th2 type immune status of the patients. It most often begins in infancy and an estimated 20% of infants and young children experience disease symptoms. Roughly 60% of those continue to have AD also in adulthood2. Children with AD are at greater risk for developing other allergic diseases like rhinitis or asthma later in life. AD is characterized by a hypersensitivity reaction occurring in the skin that causes chronic inflammation and renders the skin dry, itchy and scaly. Irritants (e.g. wool, soap), allergens and emotional stress exacerbate disease symptoms and further trigger the overactive immune system. There is no cure available. Current medications such as immunomodulators, corticosteroids or antihistamines address disease symptoms only and may be associated with sideeffects, especially upon long-term use.

About CYT003-QbG10
CYT003-QbG10 is an immunotherapeutic product in development for
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for the Treatment of Psoriasis
2. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
3. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
4. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
5. Prana Biotechnology Presents New Key Findings on PBT2
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ASCO Annual Meeting
7. Generex Biotechnology Vaccine Strategy Presented at International Conference in London
8. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
9. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
10. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
11. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
Post Your Comments:
(Date:7/31/2014)... CHESTERBROOK, Pa. , July 31, 2014 /PRNewswire/ ... AUXL ), a specialty biopharmaceutical company, today ... million regulatory milestone payment from its partner Asahi ... due because of the successful submission of a ... Device Agency (PMDA) for XIAFLEX ® (collagenase ...
(Date:7/31/2014)... , 31 juli 2014 De Pfizer Clinical ... rekruteringscampagne voor gezonde vrijwilligers van Japanse komaf voor medewerking ... gevestigde PCRU is één van twee onderzoekseenheden ... ideaal levens te verbeteren door de ontdekking en ontwikkeling ... PCRU op zoek naar mannen en vrouwen van Japanse ...
(Date:7/30/2014)... -- Hologic, Inc. (NASDAQ: HOLX ) today announced ... 28, 2014. Third Quarter Financial Highlights and ... million, reflecting operational growth of 0.5% and a positive ... in the prior year. , Revenues grew in ... revenues grew 3.5%. , GYN Surgical revenues grew ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 5Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 3Hologic Announces Third Quarter Fiscal 2014 Operating Results 4Hologic Announces Third Quarter Fiscal 2014 Operating Results 5Hologic Announces Third Quarter Fiscal 2014 Operating Results 6Hologic Announces Third Quarter Fiscal 2014 Operating Results 7Hologic Announces Third Quarter Fiscal 2014 Operating Results 8Hologic Announces Third Quarter Fiscal 2014 Operating Results 9Hologic Announces Third Quarter Fiscal 2014 Operating Results 10Hologic Announces Third Quarter Fiscal 2014 Operating Results 11Hologic Announces Third Quarter Fiscal 2014 Operating Results 12Hologic Announces Third Quarter Fiscal 2014 Operating Results 13Hologic Announces Third Quarter Fiscal 2014 Operating Results 14Hologic Announces Third Quarter Fiscal 2014 Operating Results 15Hologic Announces Third Quarter Fiscal 2014 Operating Results 16Hologic Announces Third Quarter Fiscal 2014 Operating Results 17
... PITTSBURGH , July 14 D3 Radiation Services announced ... service designed to reduce errors in the delivery of radiation therapy--as a ... , , , ... participating clinics and radiation oncology physicists can order a comprehensive audit of ...
... PITTSBURGH , July 14 Mylan Inc. ... Matrix Laboratories Limited has received final approval from the ... New Drug Application (ANDA) for Nabumetone Tablets USP, 500 ... be bioequivalent and, therefore, therapeutically equivalent to Nabumetone Tablets, ...
Cached Medicine Technology:eDataAudit Receives Approval from the American Board of Radiology 2Mylan Receives Approval for Nabumetone Tablets 2
(Date:7/31/2014)... THURSDAY, July 31, 2014 (HealthDay News) -- A new report ... made to their doctor,s office involved diabetes, with the greatest ... the U.S. Centers for Disease Control and Prevention found the ... age group jumped by 34 percent between 2005 and 2010. ... and managing the blood sugar disease costs almost $245 billion ...
(Date:7/31/2014)... Kansas City, MO (PRWEB) July 31, 2014 ... recently recognized with an Excellence Through Insight award for ... Healthcare Providers and Systems (CG-CAHPS) database in multiple categories ... honor for their commitment to excellence in patient care. ... must have been a patient satisfaction-tracking client of HealthStream ...
(Date:7/31/2014)... 2014 With the brand change comes more ... lecture series featuring the “reality model” used by Franklin ... more affordable resort pricing structure, and a renewed focus on ... have always had a great weight loss program, we really ... Ridge. We want to change the way people feel about ...
(Date:7/31/2014)... previously linked to cognitive impairment in older adults ... according to investigators from the Regenstrief Institute, ... University of East Anglia and several other United ... more than a decade of studies on the ... that these drugs have a significant adverse effect ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 RankingBySEO, a ... for those individuals and organizations against whom negative reviews ... ‘Remove Negative Comments Service’. , About the service, ... have officially announced the service now, but we have ... of negative comments for several years.” , On being ...
Breaking Medicine News(10 mins):Health News:Big Jump in Doctor's Office Visits for Young Adults With Diabetes 2Health News:Saint Luke’s Health System Physicians and Clinics Earn Excellence through Insight Awards for Overall Patient Experience in the CG-CAHPS Database 2Health News:Saint Luke’s Health System Physicians and Clinics Earn Excellence through Insight Awards for Overall Patient Experience in the CG-CAHPS Database 3Health News:Weight Loss Destination, the Biggest Loser Resort in Utah, Rebrands as Fitness Ridge 2Health News:Common drugs adversely impair older adults' physical as well as cognitive functioning 2Health News:RankingBySEO Launches a New Service ‘Remove Negative Comments’ 2
... 24 (HealthDay News) -- Morbidly obese patients who undergo spinal ... and also face higher hospital costs, a new study says. ... spinal pain. People with a body mass index (BMI) of ... generally 50 to 100 percent over their ideal body weight, ...
... , WEDNESDAY, May 23 (HealthDay News) -- The risk of ... travel more slowly through the lower chambers of the heart, ... heart and cause it to pump blood through its four ... be measured using an electrocardiogram (ECG). The waves traveling through ...
... the most comprehensive analyses to date of the cost of ... that this now-dominant surgical approach is significantly more costly than ... patient outcomes. The results of the study are available online ... Urology . In one of the first ...
... that maintain healthy nerve connections as we age help keep ... charity Age UK has found. Older people with robust ... different, distant brain areas can process information quickly and ... According to the findings, joining distant parts of the ...
... , WEDNESDAY, May 23 (HealthDay News) -- The ... reduced through a multi-pronged approach that includes more training ... to a new German study. Despite legal regulations ... as bed rails and belts still are frequently used ...
... Minn. -- Mayo Clinic researchers will present findings on ... at the annual meeting of the American Urological Association ... be available to provide expert comment for reporters covering ... presented and their embargo dates include: No ...
Cached Medicine News:Health News:Severely Obese Have More Complications With Spinal Surgery 2Health News:Study Spots Early Warning Signal for Sudden Cardiac Death 2Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 2Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 3Health News:Well-connected brains make you smarter in older age 2Health News:Study Offers Ways to Decrease Use of Restraints at Nursing Homes 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 3Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 4
The AcuMatch M-Series modular femoral stem is a unique, innovative three-piece modular stem designed to address even the most complicated of clinical indications....
Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
The link ribbed hip stem for cementless primary hip replacement surgery....
The uncemented hip joint prosthesis system...
Medicine Products: